OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of resistance to bispecific T cell engagers in multiple myeloma and their clinical implications
Éric Letouzé, Philippe Moreau, Nikhil Munshi, et al.
Blood Advances (2024) Vol. 8, Iss. 11, pp. 2952-2959
Open Access | Times Cited: 8
Éric Letouzé, Philippe Moreau, Nikhil Munshi, et al.
Blood Advances (2024) Vol. 8, Iss. 11, pp. 2952-2959
Open Access | Times Cited: 8
Showing 8 citing articles:
From Biology to Clinical Practice: The Bone Marrow Microenvironment in Multiple Myeloma
Despina Fotiou, Eirini Katodritou
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 327-327
Open Access | Times Cited: 1
Despina Fotiou, Eirini Katodritou
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 327-327
Open Access | Times Cited: 1
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access | Times Cited: 1
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access | Times Cited: 1
Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical Implications
Sihong Li, Jiahui Liu, Madeline Peyton, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 653-653
Open Access
Sihong Li, Jiahui Liu, Madeline Peyton, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 653-653
Open Access
Comprehensive analysis of adverse events associated with T-cell engagers using the FAERS database
Xiangyang Le, Yefu Zhang, Junlong Ma
Expert Opinion on Drug Safety (2025)
Closed Access
Xiangyang Le, Yefu Zhang, Junlong Ma
Expert Opinion on Drug Safety (2025)
Closed Access
Addressing practical challenges with bispecific antibody therapy in multiple myeloma
Sreeraj Vasudevan, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-7
Closed Access
Sreeraj Vasudevan, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-7
Closed Access
Mechanistic insights into resistance mechanisms to T cell engagers
Liping Cao, Gabrielle Leclercq-Cohen, Christian Klein, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Liping Cao, Gabrielle Leclercq-Cohen, Christian Klein, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: where do we stand today?
Xiang Zhou, K. Martin Kortuem, Leo Rasche, et al.
La Presse Médicale (2024), pp. 104265-104265
Open Access | Times Cited: 2
Xiang Zhou, K. Martin Kortuem, Leo Rasche, et al.
La Presse Médicale (2024), pp. 104265-104265
Open Access | Times Cited: 2
